Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001539497-21-000794
Filing Date
2021-06-07
Accepted
2021-06-07 13:35:05
Documents
1
Period of Report
2021-06-04

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES ownership.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES ownership.xml 4 3237
  Complete submission text file 0001539497-21-000794.txt   4973
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Issuer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1905 S AUDUBON CT SPOKANE WA 99224
Business Address
Sheikh Michael (Reporting) CIK: 0001640636 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35027 | Film No.: 21999007